A Randomized Phase 2 Study Evaluating the Safety, Pharmacokinetics and Efficacy of Venetoclax in Combination With Azacitidine Compared With Azacitidine Alone in Subjects With Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)
Phase of Trial: Phase II
Latest Information Update: 12 Jun 2017
At a glance
- Drugs Azacitidine (Primary) ; Azacitidine (Primary) ; Venetoclax (Primary)
- Indications Myelodysplastic syndromes
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Sponsors AbbVie
- 09 Jun 2017 This trial has been suspended in Germany.
- 07 Jun 2017 Status changed from recruiting to suspended.
- 06 Jun 2017 Status changed from suspended to recruiting.